世界のアミホスチン販売市場2021

QYResearchが発行した調査報告書(QYR21JN7553)
◆英語タイトル:Global Amifostine Sales Market Report 2021
◆商品コード:QYR21JN7553
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月7日
◆ページ数:131
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥810,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,080,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のアミホスチン市場について種類別(400mg /用量、500mg /用量)、用途別(頭頸部がん補助療法、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・アミホスチン市場の概要
・世界の主要地域別アミホスチン市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のアミホスチン市場規模2016-2021:種類別(400mg /用量、500mg /用量)
・世界のアミホスチン市場予測2012-2027:種類別(400mg /用量、500mg /用量)
・世界のアミホスチン市場規模2016-2021:用途別(頭頸部がん補助療法、その他)
・世界のアミホスチン市場予測2012-2027:用途別(頭頸部がん補助療法、その他)
・アミホスチンのアメリカ市場規模と予測2016-2021
・アミホスチンのヨーロッパ市場規模と予測2016-2021
・アミホスチンの中国市場規模と予測2016-2021
・アミホスチンの日本市場規模と予測2016-2021
・アミホスチンの東南アジア市場規模と予測2016-2021
・アミホスチンのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Clinigen、Sun Pharmaceutical、Taj Pharmaceuticals、Merro Pharmaceutical、Luye Pharma、Mingren Pharma)
・アミホスチンの製造コスト分析
・販売チャネル、流通業者、顧客
・アミホスチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.

Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.

The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen , Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.

Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment.

Market Analysis and Insights: Global Amifostine Market
The global Amifostine market was valued at US$ 53 in 2020 and will reach US$ 60 million by the end of 2027, growing at a CAGR of 2.2% during 2022-2027.

Global Amifostine Scope and Market Size
The global Amifostine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amifostine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
400mg/Dose
500mg/Dose

Segment by Application
Head and Neck Cancer Adjuvant Therapy
Others

The Amifostine market is analysed and market size information is provided by regions (countries). Segment by Application, the Amifostine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma

【レポートの目次】

1 Amifostine Market Overview
1.1 Amifostine Product Scope
1.2 Amifostine Segment by Type
1.2.1 Global Amifostine Sales by Type (2016 & 2021 & 2027)
1.2.2 400mg/Dose
1.2.3 500mg/Dose
1.3 Amifostine Segment by Application
1.3.1 Global Amifostine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Amifostine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Amifostine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Amifostine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Amifostine Price Trends (2016-2027)

2 Amifostine Estimates and Forecasts by Region
2.1 Global Amifostine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Amifostine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Amifostine Sales Market Share by Region (2016-2021)
2.2.2 Global Amifostine Revenue Market Share by Region (2016-2021)
2.3 Global Amifostine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Amifostine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Amifostine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Amifostine Estimates and Projections (2016-2027)
2.4.2 Europe Amifostine Estimates and Projections (2016-2027)
2.4.3 China Amifostine Estimates and Projections (2016-2027)
2.4.4 Japan Amifostine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Amifostine Estimates and Projections (2016-2027)
2.4.6 India Amifostine Estimates and Projections (2016-2027)
3 Global Amifostine Competition Landscape by Players
3.1 Global Top Amifostine Players by Sales (2016-2021)
3.2 Global Top Amifostine Players by Revenue (2016-2021)
3.3 Global Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amifostine as of 2020)
3.4 Global Amifostine Average Price by Company (2016-2021)
3.5 Manufacturers Amifostine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Amifostine Market Size by Type
4.1 Global Amifostine Historic Market Review by Type (2016-2021)
4.1.1 Global Amifostine Sales Market Share by Type (2016-2021)
4.1.2 Global Amifostine Revenue Market Share by Type (2016-2021)
4.1.3 Global Amifostine Price by Type (2016-2021)
4.2 Global Amifostine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Amifostine Sales Forecast by Type (2022-2027)
4.2.2 Global Amifostine Revenue Forecast by Type (2022-2027)
4.2.3 Global Amifostine Price Forecast by Type (2022-2027)
5 Global Amifostine Market Size by Application
5.1 Global Amifostine Historic Market Review by Application (2016-2021)
5.1.1 Global Amifostine Sales Market Share by Application (2016-2021)
5.1.2 Global Amifostine Revenue Market Share by Application (2016-2021)
5.1.3 Global Amifostine Price by Application (2016-2021)
5.2 Global Amifostine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Amifostine Sales Forecast by Application (2022-2027)
5.2.2 Global Amifostine Revenue Forecast by Application (2022-2027)
5.2.3 Global Amifostine Price Forecast by Application (2022-2027)

6 North America Amifostine Market Facts & Figures
6.1 North America Amifostine Sales by Company
6.1.1 North America Amifostine Sales by Company (2016-2021)
6.1.2 North America Amifostine Revenue by Company (2016-2021)
6.2 North America Amifostine Sales Breakdown by Type
6.2.1 North America Amifostine Sales Breakdown by Type (2016-2021)
6.2.2 North America Amifostine Sales Breakdown by Type (2022-2027)
6.3 North America Amifostine Sales Breakdown by Application
6.3.1 North America Amifostine Sales Breakdown by Application (2016-2021)
6.3.2 North America Amifostine Sales Breakdown by Application (2022-2027)

7 Europe Amifostine Market Facts & Figures
7.1 Europe Amifostine Sales by Company
7.1.1 Europe Amifostine Sales by Company (2016-2021)
7.1.2 Europe Amifostine Revenue by Company (2016-2021)
7.2 Europe Amifostine Sales Breakdown by Type
7.2.1 Europe Amifostine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Amifostine Sales Breakdown by Type (2022-2027)
7.3 Europe Amifostine Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Amifostine Market Facts & Figures
8.1 China Amifostine Sales by Company
8.1.1 China Amifostine Sales by Company (2016-2021)
8.1.2 China Amifostine Revenue by Company (2016-2021)
8.2 China Amifostine Sales Breakdown by Type
8.2.1 China Amifostine Sales Breakdown by Type (2016-2021)
8.2.2 China Amifostine Sales Breakdown by Type (2022-2027)
8.3 China Amifostine Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Amifostine Market Facts & Figures
9.1 Japan Amifostine Sales by Company
9.1.1 Japan Amifostine Sales by Company (2016-2021)
9.1.2 Japan Amifostine Revenue by Company (2016-2021)
9.2 Japan Amifostine Sales Breakdown by Type
9.2.1 Japan Amifostine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Amifostine Sales Breakdown by Type (2022-2027)
9.3 Japan Amifostine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Amifostine Market Facts & Figures
10.1 Southeast Asia Amifostine Sales by Company
10.1.1 Southeast Asia Amifostine Sales by Company (2016-2021)
10.1.2 Southeast Asia Amifostine Revenue by Company (2016-2021)
10.2 Southeast Asia Amifostine Sales Breakdown by Type
10.2.1 Southeast Asia Amifostine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Amifostine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Amifostine Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Amifostine Market Facts & Figures
11.1 India Amifostine Sales by Company
11.1.1 India Amifostine Sales by Company (2016-2021)
11.1.2 India Amifostine Revenue by Company (2016-2021)
11.2 India Amifostine Sales Breakdown by Type
11.2.1 India Amifostine Sales Breakdown by Type (2016-2021)
11.2.2 India Amifostine Sales Breakdown by Type (2022-2027)
11.3 India Amifostine Sales Breakdown by Application
11.3.1 India Amifostine Sales Breakdown by Application (2016-2021)
11.3.2 India Amifostine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Amifostine Business
12.1 Clinigen
12.1.1 Clinigen Corporation Information
12.1.2 Clinigen Business Overview
12.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Clinigen Amifostine Products Offered
12.1.5 Clinigen Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Corporation Information
12.2.2 Sun Pharmaceutical Business Overview
12.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sun Pharmaceutical Amifostine Products Offered
12.2.5 Sun Pharmaceutical Recent Development
12.3 Taj Pharmaceuticals
12.3.1 Taj Pharmaceuticals Corporation Information
12.3.2 Taj Pharmaceuticals Business Overview
12.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Taj Pharmaceuticals Amifostine Products Offered
12.3.5 Taj Pharmaceuticals Recent Development
12.4 Merro Pharmaceutical
12.4.1 Merro Pharmaceutical Corporation Information
12.4.2 Merro Pharmaceutical Business Overview
12.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merro Pharmaceutical Amifostine Products Offered
12.4.5 Merro Pharmaceutical Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Corporation Information
12.5.2 Luye Pharma Business Overview
12.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Luye Pharma Amifostine Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Mingren Pharma
12.6.1 Mingren Pharma Corporation Information
12.6.2 Mingren Pharma Business Overview
12.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Mingren Pharma Amifostine Products Offered
12.6.5 Mingren Pharma Recent Development

13 Amifostine Manufacturing Cost Analysis
13.1 Amifostine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Amifostine
13.4 Amifostine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Amifostine Distributors List
14.3 Amifostine Customers

15 Market Dynamics
15.1 Amifostine Market Trends
15.2 Amifostine Drivers
15.3 Amifostine Market Challenges
15.4 Amifostine Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のアミホスチン販売市場2021(Global Amifostine Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。